Compare SPRO & LINK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPRO | LINK |
|---|---|---|
| Founded | 2013 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 59.5M |
| IPO Year | 2017 | 2007 |
| Metric | SPRO | LINK |
|---|---|---|
| Price | $1.20 | $5.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.67 |
| AVG Volume (30 Days) | ★ 1.5M | 16.0K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 111.81 | 45.83 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $66,802,000.00 | $11,890,000.00 |
| Revenue This Year | N/A | $43.26 |
| Revenue Next Year | $300.00 | $19.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 39.24 | 1.81 |
| 52 Week Low | $1.08 | $2.66 |
| 52 Week High | $3.08 | $15.15 |
| Indicator | SPRO | LINK |
|---|---|---|
| Relative Strength Index (RSI) | 31.16 | 54.24 |
| Support Level | $1.10 | $3.58 |
| Resistance Level | $1.28 | $6.06 |
| Average True Range (ATR) | 0.06 | 0.43 |
| MACD | 0.04 | 0.08 |
| Stochastic Oscillator | 40.00 | 58.69 |
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.
Interlink Electronics Inc is a sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.